SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-018718
Filing Date
2024-05-13
Accepted
2024-05-10 18:08:50
Documents
60
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 981599
2 ex31-1.htm EX-31.1 18987
3 ex31-2.htm EX-31.2 18852
4 ex32-1.htm EX-32.1 8347
5 ex32-2.htm EX-32.2 8347
  Complete submission text file 0001493152-24-018718.txt   5590941

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ensc-20240331.xsd EX-101.SCH 41157
7 XBRL CALCULATION FILE ensc-20240331_cal.xml EX-101.CAL 44756
8 XBRL DEFINITION FILE ensc-20240331_def.xml EX-101.DEF 169604
9 XBRL LABEL FILE ensc-20240331_lab.xml EX-101.LAB 340933
10 XBRL PRESENTATION FILE ensc-20240331_pre.xml EX-101.PRE 266279
64 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 853189
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38306 | Film No.: 24936363
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)